Literature DB >> 25836352

Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicity.

Frank J Gonzalez1, Zhong-Ze Fang, Xiaochao Ma.   

Abstract

INTRODUCTION: The study of xenobiotic metabolism and toxicity has been greatly aided by the use of genetically modified mouse models and metabolomics. AREAS COVERED: Gene knockout mice can be used to determine the enzymes responsible for the metabolism of xenobiotics in vivo and to examine the mechanisms of xenobiotic-induced toxicity. Humanized mouse models are especially important because there exist marked species differences in the xenobiotic-metabolizing enzymes and the nuclear receptors that regulate these enzymes. Humanized mice expressing CYPs and nuclear receptors including the pregnane X receptor, the major regulator of xenobiotic metabolism and transport were produced. With genetically modified mouse models, metabolomics can determine the metabolic map of many xenobiotics with a level of sensitivity that allows the discovery of even minor metabolites. This technology can be used for determining the mechanism of xenobiotic toxicity and to find early biomarkers for toxicity. EXPERT OPINION: Metabolomics and genetically modified mouse models can be used for the study of xenobiotic metabolism and toxicity by: i) comparison of the metabolomics profiles between wild-type and genetically modified mice, and searching for genotype-dependent endogenous metabolites; ii) searching for and elucidating metabolites derived from xenobiotics; and iii) discovery of specific alterations of endogenous compounds induced by xenobiotics-induced toxicity.

Entities:  

Keywords:  CYP; CYP3A4; UPLC-ESI-QTOFMS; genetically modified mice; metabolomics; pregnane X receptor; xenobiotics

Mesh:

Substances:

Year:  2015        PMID: 25836352      PMCID: PMC4706076          DOI: 10.1517/17425255.2015.1032245

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  99 in total

1.  The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism.

Authors:  P Wei; J Zhang; M Egan-Hafley; S Liang; D D Moore
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

Review 2.  Metabonomics: a platform for studying drug toxicity and gene function.

Authors:  Jeremy K Nicholson; John Connelly; John C Lindon; Elaine Holmes
Journal:  Nat Rev Drug Discov       Date:  2002-02       Impact factor: 84.694

3.  Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam.

Authors:  Camille P Granvil; Ai-Ming Yu; Guillermo Elizondo; Taro E Akiyama; Connie Cheung; Lionel Feigenbaum; Kristopher W Krausz; Frank J Gonzalez
Journal:  Drug Metab Dispos       Date:  2003-05       Impact factor: 3.922

4.  Membrane transporters and drug development: relevance to pharmacogenomics, nutrigenomics, epigenetics, and systems biology.

Authors:  Qing Yan
Journal:  Methods Mol Biol       Date:  2010

Review 5.  Knockout and transgenic mice in glutathione transferase research.

Authors:  Colin J Henderson; C Roland Wolf
Journal:  Drug Metab Rev       Date:  2011-03-22       Impact factor: 4.518

6.  The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.

Authors:  S A Jones; L B Moore; J L Shenk; G B Wisely; G A Hamilton; D D McKee; N C Tomkinson; E L LeCluyse; M H Lambert; T M Willson; S A Kliewer; J T Moore
Journal:  Mol Endocrinol       Date:  2000-01

7.  Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.

Authors:  J F Denissen; B A Grabowski; M K Johnson; A M Buko; D J Kempf; S B Thomas; B W Surber
Journal:  Drug Metab Dispos       Date:  1997-04       Impact factor: 3.922

Review 8.  Application of in vivo metabolomics to preclinical/toxicological studies: case study on phenytoin-induced systemic toxicity.

Authors:  H Kamp; E Fabian; S Groeters; M Herold; G Krennrich; R Looser; W Mattes; W Mellert; A Prokoudine; P Ruiz-Noppinger; V Strauss; T Walk; J Wiemer; B van Ravenzwaay
Journal:  Bioanalysis       Date:  2012-09       Impact factor: 2.681

Review 9.  Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.

Authors:  Sonu Sundd Singh
Journal:  Curr Drug Metab       Date:  2006-02       Impact factor: 3.731

Review 10.  Animal models for human risk assessment: the peroxisome proliferator-activated receptor alpha-humanized mouse.

Authors:  Frank J Gonzalez
Journal:  Nutr Rev       Date:  2007-06       Impact factor: 7.110

View more
  13 in total

1.  Metabolic alterations in triptolide-induced acute hepatotoxicity.

Authors:  Jie Zhao; Cen Xie; Xiyan Mu; Kristopher W Krausz; Daxesh P Patel; Xiaowei Shi; Xiaoxia Gao; Qiao Wang; Frank J Gonzalez
Journal:  Biomed Chromatogr       Date:  2018-07-04       Impact factor: 1.902

Review 2.  P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity.

Authors:  Karl-Dimiter Bissig; Weiguo Han; Mercedes Barzi; Nataliia Kovalchuk; Liang Ding; Xiaoyu Fan; Francis P Pankowicz; Qing-Yu Zhang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2018-08-09       Impact factor: 3.922

Review 3.  Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond.

Authors:  Ruizhi Gu; Alina Liang; Grace Liao; Isabelle To; Amina Shehu; Xiaochao Ma
Journal:  Drug Metab Dispos       Date:  2022-02-27       Impact factor: 3.579

4.  Age-Specific Regulation of Drug-Processing Genes in Mouse Liver by Ligands of Xenobiotic-Sensing Transcription Factors.

Authors:  Cindy Yanfei Li; Helen J Renaud; Curtis D Klaassen; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2015-11-17       Impact factor: 3.922

Review 5.  Combining Chimeric Mice with Humanized Liver, Mass Spectrometry, and Physiologically-Based Pharmacokinetic Modeling in Toxicology.

Authors:  Hiroshi Yamazaki; Hiroshi Suemizu; Marina Mitsui; Makiko Shimizu; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2016-07-05       Impact factor: 3.739

Review 6.  The safety evaluation of food flavouring substances: the role of metabolic studies.

Authors:  Robert L Smith; Samuel M Cohen; Shoji Fukushima; Nigel J Gooderham; Stephen S Hecht; F Peter Guengerich; Ivonne M C M Rietjens; Maria Bastaki; Christie L Harman; Margaret M McGowen; Sean V Taylor
Journal:  Toxicol Res (Camb)       Date:  2018-03-28       Impact factor: 3.524

Review 7.  Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models.

Authors:  Sheila Annie Peters; Christopher R Jones; Anna-Lena Ungell; Oliver J D Hatley
Journal:  Clin Pharmacokinet       Date:  2016-06       Impact factor: 6.447

8.  Revisiting the Metabolism and Bioactivation of Ketoconazole in Human and Mouse Using Liquid Chromatography-Mass Spectrometry-Based Metabolomics.

Authors:  Ju-Hyun Kim; Won-Gu Choi; Sangkyu Lee; Hye Suk Lee
Journal:  Int J Mol Sci       Date:  2017-03-13       Impact factor: 5.923

9.  Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR/Cas9: a novel model for drug transport and hyperbilirubinemia disease.

Authors:  Xinrun Ma; Xuyang Shang; Xuan Qin; Jian Lu; Mingyao Liu; Xin Wang
Journal:  Acta Pharm Sin B       Date:  2019-11-14       Impact factor: 11.413

Review 10.  The role of cytochrome P450 enzymes in carcinogen activation and detoxication: an in vivo-in vitro paradox.

Authors:  Lindsay Reed; Volker M Arlt; David H Phillips
Journal:  Carcinogenesis       Date:  2018-07-03       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.